Animal cell biotechnology: culture, monoclonal antibodies and recombinant proteins
Cell culture, monoclonal antibodies, recombinant proteins and their uses, explained for university biology, with practice questions.
On this page
Animal cell biotechnology is the use of cultured animal cells to make useful products, from monoclonal antibodies and vaccines to therapeutic proteins and cell therapies. It covers how cells are grown outside the body, how they are engineered to produce a protein of interest, and how those products are purified and used in medicine. This guide explains primary cells and cell lines, hybridoma technology, recombinant protein production in CHO cells and the main applications, then gives you practice questions with mark-scheme style answers.
What is animal cell biotechnology?
Animal cell biotechnology is the branch of biotechnology that grows and engineers animal cells (usually mammalian) to produce medicines and study biology. It is distinct from fermentation in bacteria or yeast because animal cells can carry out the complex processing that human proteins need, such as correct folding and the addition of sugar groups.
Animal cell culture is the practice at the centre of it: keeping animal cells alive and dividing in a controlled vessel, in a liquid medium that supplies nutrients, growth factors and the right conditions. Once you can grow cells reliably, you can use them as tiny factories, as test systems for drugs, or as the therapy itself.
Primary cells and cell lines
Cells grown in the lab fall into two broad groups, and the difference matters for every experiment.
A primary cell is taken directly from a tissue and grown in culture. It keeps the characteristics of the tissue it came from, which makes it biologically realistic, but it divides only a limited number of times before it stops (replicative senescence). You have to isolate fresh cells each time.
A cell line divides indefinitely. Some lines arise from tumours, some are made immortal in the lab, and once established they can be frozen, shared and grown again and again. The first immortal human line, HeLa cells, came from a cervical tumour in 1951 and is still used worldwide. Immortality makes cell lines convenient and reproducible, but years of division can change their genetics, so they drift away from the original tissue.
Keeping cultures alive: media, conditions and contamination
Growth medium supplies the cells with amino acids, glucose, vitamins, salts and buffering. Many media are still supplemented with serum (often foetal bovine serum) for growth factors, though serum-free and chemically defined media are preferred for making medicines because they are more consistent and avoid animal-derived risks. A pH indicator such as phenol red shows at a glance whether the medium has turned acidic.
Most mammalian cells are grown at 37°C in a humidified incubator with around 5% carbon dioxide, which works with a bicarbonate buffer to hold the pH steady. Cells grow either attached to a surface (adherent culture) or free in liquid (suspension culture), and are passaged when they become crowded.
Contamination is the constant threat. Bacteria and fungi grow fast and are usually obvious, but mycoplasma are tiny, slow and invisible down a normal microscope, yet they change how cells behave. Cross-contamination by other cell lines is a separate and serious problem: a register of misidentified lines listed 608 cell lines in version 14, released on 15 February 2026. Good aseptic technique, working in a laminar-flow hood, regular mycoplasma testing and authenticating the identity of a line all guard against wasted or misleading results.
How hybridoma technology makes monoclonal antibodies
A monoclonal antibody is a single, identical antibody made by one clone of cells, so every molecule binds the same target in the same way. The method that made them practical earned the 1984 Nobel Prize for Georges Köhler and César Milstein, who described the hybridoma technique in 1975 (they shared it with Niels Jerne).
The problem it solves is simple to state. A plasma cell (a type of B cell) makes exactly the antibody you want, but it dies quickly in culture. A myeloma (tumour) cell divides forever, but it makes the wrong antibody or none. Fuse the two and you get a hybridoma that does both.
- Immunise a mouse with the antigen. Its B cells make antibodies against it.
- Collect B cells from the mouse's spleen.
- Fuse these B cells with immortal myeloma cells, usually using polyethylene glycol or an electric pulse. The myeloma line is chosen so that it lacks the enzyme HGPRT and does not secrete its own antibody.
- Grow the mixture in HAT medium. The drug aminopterin blocks the cell's main route for making nucleotides, so cells must use the backup salvage pathway, which needs HGPRT. Unfused myeloma cells lack HGPRT and die; unfused B cells die naturally after a few divisions. Only fused hybridomas survive, because they gain HGPRT from the B cell and immortality from the myeloma cell.
- Screen the surviving hybridomas and pick one that makes the antibody you want. Clone it by limiting dilution, so every cell comes from a single parent.
- Scale up the chosen clone. It secretes identical, monoclonal antibodies that you then purify.
Recombinant proteins: why CHO cells beat bacteria
A recombinant protein is one made by inserting the gene for it into a host cell. For many human therapeutic proteins, the host of choice is the Chinese hamster ovary (CHO) cell line rather than bacteria such as E. coli.
The reason is post-translational processing. Human proteins often need glycosylation, the addition of specific sugar chains, to fold correctly, stay stable and work in the body. Bacteria cannot add these mammalian sugars, and they often misfold large proteins into insoluble clumps called inclusion bodies. Mammalian cells add human-like glycosylation and secrete the protein into the medium, which makes purification easier. A 2018 survey of approved biopharmaceuticals found CHO cells are by far the most common mammalian production host: 57 of the 68 monoclonal antibodies approved in the US or EU from January 2014 to July 2018 (84%) were made in them.
Bacteria still have their place. They grow fast, cost little and give high yields, so they suit smaller proteins that do not need glycosylation, such as insulin.
| Feature | CHO cells | E. coli |
|---|---|---|
| Glycosylation | Human-like sugars added | None |
| Folding | Folds large, complex proteins | Often misfolds, inclusion bodies |
| Product location | Secreted into medium | Usually inside the cell |
| Yield and cost | Lower yield, higher cost | High yield, low cost |
| Growth speed | Days to weeks | Hours |
| Typical products | Antibodies, clotting factors | Insulin, growth hormone |
Source: Walsh, Biopharmaceutical benchmarks 2018. Last checked: 19 November 2026.
What animal cell biotechnology is used for
Antibody therapeutics. Many of the best-known biological medicines are monoclonal antibodies made in CHO cells. Trastuzumab, sold as Herceptin, is a humanised antibody against the HER2 protein used in some breast cancers, and its product information states it is produced in Chinese hamster ovary cell culture.
Vaccines. Viruses for some vaccines are grown in cultured animal cells rather than hens' eggs. The cell-based influenza vaccine Flucelvax is grown in MDCK (Madin-Darby canine kidney) cells, which avoids egg-based manufacturing and the mutations that can arise when flu strains are grown in eggs.
Cell and gene therapy. Here the cells are the product. Casgevy, authorised by the UK MHRA on 15 November 2023 for patients aged 12 and over, takes a patient's own blood stem cells, edits them in the laboratory to switch on healthy haemoglobin, and infuses them back. It was the first licensed medicine to use CRISPR gene editing.
If you want to firm up the cell biology this builds on, Medly covers animal cell structure at GCSE and A-Level, and the wider lab disciplines sit alongside it in our guide to biomedical science. Medly's free plan gives you 5 marked questions and 20 AI tutor messages a day, with no card needed.
Worked example: cell counting and viability on a haemocytometer
Counting cells with a haemocytometer and trypan blue is a core practical skill. Trypan blue enters dead cells and stains them, while live cells stay clear, so you can measure both density and viability at once.
Worked example (5 marks)
You mix the cell suspension 1 part to 1 part with trypan blue, then count the four corner squares. The unstained (live) counts are 92, 88, 95 and 85. You also count 40 stained (dead) cells across the four squares. Work out the live cell density in cells per mL and the percentage viability.
- Mean live count per square = (92 + 88 + 95 + 85) ÷ 4 = 360 ÷ 4 = 90.
- Dilution factor = 2 (a 1 to 1 mix doubles the volume).
- Each corner square = 1 × 10⁻⁴ mL, so cells per mL = mean × dilution factor × 10⁴.
- Live cell density = 90 × 2 × 10⁴ = 1.8 × 10⁶ cells/mL.
- Total cells counted = 360 live + 40 dead = 400. Viability = 360 ÷ 400 × 100 = 90%.
The common slip is forgetting the dilution factor, or using the volume of one square instead of the 10⁴ conversion to a millilitre.
Animal cell biotechnology exam questions with answers
Try these before you check the answers.
Question 1: (1 mark)
Why are therapeutic monoclonal antibodies usually produced in mammalian cells rather than in E. coli?
A. Mammalian cells grow faster than E. coli
B. Mammalian cells add human-like glycosylation that affects the antibody's function and half-life
C. E. coli cannot synthesise any protein
D. Mammalian culture is cheaper than bacterial culture
Answer
B. Mammalian cells add human-like glycosylation that affects the antibody's function and half-life.
E. coli cannot carry out mammalian glycosylation and often misfolds large proteins, so the antibody may not work or may be cleared quickly from the body.
Question 2: (4 marks)
A cell suspension is mixed 1 part to 1 part with trypan blue. Counting the four corner squares of a haemocytometer gives live counts of 70, 74, 72 and 64, plus 20 stained cells in total. Each corner square holds 1 × 10⁻⁴ mL. Work out the live cell density in cells per mL and the percentage viability.
Answer
- Mean live count = (70 + 74 + 72 + 64) ÷ 4 = 280 ÷ 4 = 70.
- Dilution factor = 2.
- Live cell density = 70 × 2 × 10⁴ = 1.4 × 10⁶ cells/mL.
- Total counted = 280 live + 20 dead = 300. Viability = 280 ÷ 300 × 100 = 93.3%.
Marks: mean (1), applying the dilution factor and 10⁴ conversion (1), correct density (1), correct viability (1).
Question 3: (4 marks)
In hybridoma production, explain how HAT medium ensures that only fused hybridoma cells survive.
Answer
- Aminopterin blocks the main (de novo) pathway for making nucleotides, so cells must use the salvage pathway instead.
- The salvage pathway needs the enzyme HGPRT.
- The myeloma cells used lack HGPRT, so unfused myeloma cells cannot use the salvage pathway and die.
- Unfused B cells die naturally after a few divisions, so only fused hybridomas, which gain HGPRT from the B cell and immortality from the myeloma cell, survive and grow.
Question 4: (3 marks)
Mycoplasma is a common contaminant of mammalian cell cultures. Explain why it is a particular problem and give two measures used to control contamination.
Answer
- Mycoplasma are very small and slow-growing, so unlike bacteria or fungi they do not make the medium cloudy and cannot be seen with a standard light microscope, yet they change how the cells behave and can invalidate results (1).
- Any two control measures (1 each): working with aseptic technique in a laminar-flow hood; routine mycoplasma testing; using antibiotics appropriately; authenticating and quarantining new cell lines before use; discarding contaminated stocks.
Frequently asked questions
What is animal cell biotechnology in simple terms?
It is growing and engineering animal cells in the lab to make useful products, such as antibodies, vaccines and therapeutic proteins, or to use the cells themselves as a treatment.
What is the difference between a primary cell and a cell line?
A primary cell comes straight from a tissue and divides only a limited number of times. A cell line divides indefinitely, so it can be frozen, shared and grown repeatedly, though its genetics may drift over time.
Why are monoclonal antibodies made in mammalian cells and not bacteria?
Because antibodies need correct folding and human-like glycosylation to work and to last in the body. Bacteria cannot add these sugars and often misfold large proteins, so mammalian cells such as CHO are used instead.
What is HAT medium used for?
HAT medium selects for hybridomas. Its aminopterin forces cells onto the salvage pathway, which needs HGPRT, so only fused cells that have both HGPRT and immortality survive.
Is HeLa a primary cell or a cell line?
HeLa is a cell line. It was the first immortal human cell line, established from a cervical tumour in 1951, and it divides indefinitely in culture.